ArisGlobal Announces NavaX-Powered QMS, Bringing AI Innovation to Quality Management
Next-generation Quality Management System to extend the NavaX AI platform ...
Pharmaceutical Technology – Reimagining Signal Management: How Autonomous Pharmacovigilance Could Render Reporting Timelines a Thing of the Past
Lucinda discusses how autonomous pharmacovigilance and AI-driven workflows could transform signal management, enabling faster identification, assessment, and response to emerging safety risks.
Journal of mHealth – Drug Safety in the Modern Age: Is It Time for a Larger-Scale Revamp of Adverse Event Case Processing?
The article explores how advances in AI and automation are creating an opportunity to rethink adverse event case processing and broader pharmacovigilance operations, moving beyond incremental improvements toward more fundamental transformation.
Global Biopharmaceutical Company Advances Pharmaceutical Operations in Japan with LifeSphere Solutions
Deployment of LifeSphere Intake & Triage, Literature Intelligence, and Reporter enhances efficiency, ...
Drug Discovery World – Why Pharma Must Refocus Its Data Efforts If It Really Wants to Exploit AI
Based on the Life Sciences AI Exchange podcast panel discussion, the article explores why data transformation remains one of the biggest barriers to successful AI adoption in life sciences. The discussion examines the industry's ongoing challenges with fragmented data, the realities of preparing organizations for AI at scale, and the steps companies must take to create a stronger foundation for future innovation.
ArisGlobal and Sitero Expand Strategic Partnership to Advance AI Innovation across Literature Search & Monitoring and Case Management
Collaboration combines AI technology and operational expertise to help life sciences organizations ...
Top 10 Pharmaceutical Company Selects NavaX-Powered Advanced Intake and Literature Intelligence to Modernize Global Safety Intake
Modular, system-agnostic product design enables rapid deployment on top of existing safety systems ...
ArisGlobal Reports Strong Q1 2026 Momentum with Accelerating Enterprise AI Transformation Â
Expanding NavaX adoption, new Top Pharma wins, and continued global ...
ArisGlobal Expands NavaX Agents Suite with Three New AI Agents to Orchestrate Intelligence Across Life Sciences Operations
New Distribution, Signals, and Intelligence Agents reduce manual effort, streamline compliance tasks, and orchestrate end-to-end decision workflows.
ArisGlobal Launches ReporterX to Accelerate AI-Driven Collection of Patient Data from the Field
New NavaX-powered capabilities combine Dynamic Data Extraction, Translation, Conversational AI, and Intelligent Follow-up Management to modernize adverse event, medical information and product quality complaints reporting.
